{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:02Z","timestamp":1793377862217,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RC-2025-2794683"],"award-info":[{"award-number":["RC-2025-2794683"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejso.2026.111991","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:15:24Z","timestamp":1783178124000},"page":"111991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Uptake of breast cancer risk-management strategies among unaffected BRCA 1\/2 carriers: a systematic review of international evidence"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-9372","authenticated-orcid":false,"given":"Lea","family":"Godino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6909-2412","authenticated-orcid":false,"given":"Giovanni","family":"Innella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Di Palo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Raffaele","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Turchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111991_bib1","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2026.111991_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.gim.2021.08.016","article-title":"Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants","volume":"24","author":"Li","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.ejso.2026.111991_bib3","first-page":"1001","article-title":"NCCN guidelines\u00ae insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024","volume":"21","author":"Daly","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2026.111991_bib4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-Associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111991_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58070943","article-title":"Scar-free laparoscopy in BRCA-mutated women","author":"Restaino","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.ejso.2026.111991_bib6","series-title":"Prophylactic surgery to reduce the risk of developing breast cancer: issues and clinical implications","author":"Razzaboni","year":"2012"},{"key":"10.1016\/j.ejso.2026.111991_bib7","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.pec.2017.06.032","article-title":"A systematic review of women's satisfaction and regret following risk-reducing mastectomy","volume":"100","author":"Braude","year":"2017","journal-title":"Patient Educ Counsel"},{"key":"10.1016\/j.ejso.2026.111991_bib8","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis","volume":"24","author":"Heemskerk-Gerritsen","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2026.111991_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","article-title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","volume":"121","author":"Metcalfe","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2026.111991_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-014-0442-6","article-title":"The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services","volume":"16","author":"Evans","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2026.111991_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.55324","article-title":"Cost-effectiveness of gene-specific prevention strategies for ovarian and breast cancer","volume":"7","author":"Wei","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2026.111991_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.ejso.2026.111991_bib13","doi-asserted-by":"crossref","DOI":"10.7748\/nr.2023.e1866","article-title":"How to structure excel for systematic review process","volume":"31","author":"Godino","year":"2023","journal-title":"Nurse Res"},{"key":"10.1016\/j.ejso.2026.111991_bib14","first-page":"1","volume":"13","author":"Kmet","year":"2004"},{"key":"10.1016\/j.ejso.2026.111991_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3200\/BMED.31.3.93-106","article-title":"Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast\/ovarian cancer","volume":"31","author":"Claes","year":"2005","journal-title":"Behav Med (Washington, DC)"},{"key":"10.1016\/j.ejso.2026.111991_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10689-012-9539-1","article-title":"Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome","volume":"11","author":"This","year":"2012","journal-title":"Fam Cancer"},{"issue":"5 19","key":"10.1016\/j.ejso.2026.111991_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ejhg.2010.241","article-title":"Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1\/2 mutations","volume":"19","author":"Julian-Reynier","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ejso.2026.111991_bib18","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","article-title":"International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers","volume":"122","author":"Metcalfe","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2026.111991_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jmedgenet-2020-107356","article-title":"Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers","volume":"59","author":"Marcinkute","year":"2022","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejso.2026.111991_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/tbj.12978","article-title":"Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK","volume":"24","author":"Long","year":"2018","journal-title":"Breast J"},{"key":"10.1016\/j.ejso.2026.111991_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-0004.2009.01329.x","article-title":"Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing","volume":"77","author":"Skytte","year":"2010","journal-title":"Clin Genet"},{"issue":"3 214","key":"10.1016\/j.ejso.2026.111991_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10549-025-07821-4","article-title":"Time trends, uptake, and oncological effects of risk-reducing surgeries in 3067 Danish BRCA1\/2 carriers: a population-based study with matched controls","volume":"214","author":"Willert","year":"2025","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2026.111991_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1457496913490460","article-title":"The frequency and outcome of breast cancer risk-reducing surgery in finnish BRCA1 and BRCA2 mutation carriers","volume":"103","author":"Koskenvuo","year":"2014","journal-title":"Scand J Surg"},{"key":"10.1016\/j.ejso.2026.111991_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.breast.2011.04.005","article-title":"Surgical management of an Irish cohort of BRCA-mutation carriers","volume":"20","author":"Carroll","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2026.111991_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/cge.12298","article-title":"The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers","volume":"85","author":"Borreani","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejso.2026.111991_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.109571","article-title":"Risk reducing mastectomy in Norwegian BRCA1\/2 carriers","volume":"51","author":"Hyldebrandt","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111991_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/genes10121046","article-title":"Increased overall mortality Even after risk reducing surgery for BRCA-Positive women in Western Sweden","volume":"10","author":"\u00d6fverholm","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.ejso.2026.111991_bib28","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.ejso.2021.03.248","article-title":"Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia","volume":"47","author":"Lo\u017ear","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111991_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041072","article-title":"Uptake and effectiveness of risk-reducing surgeries in unaffected female BRCA1 and BRCA2 carriers: a single institution experience in the Czech Republic","volume":"15","author":"Zimovjanova","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111991_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1399-0004.2007.00742.x","article-title":"A survey of preventive measures among BRCA1 mutation carriers from Poland","volume":"71","author":"Gronwald","year":"2007","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejso.2026.111991_bib31","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.ajog.2013.01.026","article-title":"Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers","volume":"208","author":"Singh","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejso.2026.111991_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/tbj.12521","article-title":"Surgical decision making in the BRCA-positive population: institutional experience and comparison with recent literature","volume":"22","author":"Flippo-Morton","year":"2016","journal-title":"Breast J"},{"key":"10.1016\/j.ejso.2026.111991_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.breast.2011.01.006","article-title":"Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer","volume":"20","author":"Haroun","year":"2011","journal-title":"Breast"},{"issue":"133","key":"10.1016\/j.ejso.2026.111991_bib34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10549-011-1941-0","article-title":"Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening","volume":"2","author":"Metcalfe","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"2 4","key":"10.1016\/j.ejso.2026.111991_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10689-005-4215-3","article-title":"The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation","volume":"4","author":"Metcalfe","year":"2005","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ejso.2026.111991_bib36","first-page":"1115","article-title":"Utilization of breast cancer screening in a clinically based sample of women after BRCA1\/2 testing","volume":"11","author":"Peshkin","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejso.2026.111991_bib37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/jwh.2016.5931","article-title":"Breast cancer risk reduction decisions of the BRCA-positive patient: an observational study at a single institution","volume":"26","author":"Johns","year":"2017","journal-title":"J Womens Health"},{"key":"10.1016\/j.ejso.2026.111991_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10010007","article-title":"Healthcare utilization and costs after receiving a positive BRCA1\/2 result from a genomic screening program","volume":"10","author":"Hao","year":"2020","journal-title":"J Personalized Med"},{"key":"10.1016\/j.ejso.2026.111991_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10689-017-0047-1","article-title":"Cancer risk management in tasmanian women with BRCA1 and BRCA2 mutations","volume":"17","author":"Kearton","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ejso.2026.111991_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-0004.2006.00665.x","article-title":"Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"70","author":"Phillips","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejso.2026.111991_bib41","doi-asserted-by":"crossref","first-page":"680","DOI":"10.5694\/mja13.10848","article-title":"Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers","volume":"199","author":"Collins","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejso.2026.111991_bib42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cge.12149","article-title":"Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers","volume":"85","author":"Laitman","year":"2014","journal-title":"Clin Genet"},{"issue":"2 185","key":"10.1016\/j.ejso.2026.111991_bib43","first-page":"391","article-title":"Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers","volume":"185","author":"Galmor","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2026.111991_bib44","first-page":"1265","article-title":"Risk-reducing mastectomy for women with hereditary breast and ovarian cancer (HBOC): analytical results of data from the Japanese Organization of HBOC","volume":"52","author":"Ohsumi","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111991_bib45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4048\/jbc.2020.23.e61","article-title":"Trends in risk-reducing mastectomy and risk-reducing salpingo-oophorectomy in Korean carriers of the BRCA1\/2 mutation","volume":"23","author":"Jung","year":"2020","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.ejso.2026.111991_bib46","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.3390\/curroncol31110499","article-title":"Pattern anlysis of risk-reducing strategies in unaffected Korean BRCA1\/2 mutation carriers","volume":"31","author":"Kim","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejso.2026.111991_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.GOX.0001005892.62910.1b","article-title":"Surveillance Vs. Prophylactic mastectomy and reconstruction in BRCA1\/2 patients: a cost analysis study","volume":"12","author":"Subramaniam","year":"2024","journal-title":"Plastic Reconstr Surg, Glob Open"},{"key":"10.1016\/j.ejso.2026.111991_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.21037\/abs.2018.11.05","article-title":"Prophylactic mastectomy can save patients up to $50,000 compared to lifelong screening in BRCA 1 and BRCA 2 patients","volume":"2","author":"Shirley","year":"2018","journal-title":"Anna Breast Surg"},{"key":"10.1016\/j.ejso.2026.111991_bib49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/10810730.2015.1064498","article-title":"Celebrity influence and identification: a test of the angelina effect","volume":"21","author":"Kosenko","year":"2016","journal-title":"J Health Commun"},{"issue":"2 33","key":"10.1016\/j.ejso.2026.111991_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12282-026-01822-x","article-title":"Evaluating high-risk breast cancer surveillance outcomes in BRCA mutation carriers","volume":"33","author":"Chang","year":"2026","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejso.2026.111991_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","article-title":"Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer","volume":"148","author":"Warner","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejso.2026.111991_bib52","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.3390\/curroncol30040274","article-title":"Assessing psychological morbidity in cancer-unaffected BRCA1\/2 pathogenic variant carriers: a systematic review","volume":"30","author":"Isselhard","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejso.2026.111991_bib53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/gim.2014.183","article-title":"Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1\/BRCA2 mutations","volume":"17","author":"Caiata-Zufferey","year":"2015","journal-title":"Genet Med"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:32:47Z","timestamp":1793374367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326006104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0748798326006104"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111991","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake of breast cancer risk-management strategies among unaffected BRCA 1\/2 carriers: a systematic review of international evidence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111991"}}